D. Hayasaka et al., Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains, VACCINE, 19(32), 2001, pp. 4774-4779
To evaluate the efficacy of the European TBE, vaccine in east-Siberian and
far-eastern. regions of Russia, we examined the immune responses of the vac
cine against recent TBE virus Siberian (Irkutsk) and far-eastern (Khabarovs
k and Vladivostok) isolates. The sera of vaccinated humans showed efficient
neutralizing antibody titers (greater than or equal to 20) against Siberia
n and far-eastern strains. To evaluate the efficacy of the vaccine in vivo,
mice were vaccinated and challenged with lethal doses of the viruses. All
vaccinated mice survived each virus challenge. These-results suggest that t
he European vaccine can prevent the TBE virus infection in east-Siberian an
d far-eastern regions of Russia. (C) 2001 Elsevier Science Ltd. All rights
reserved.